{
    "data": [
        {
            "id": "4511965",
            "title": "Crocs outlines $100M cost savings initiative and forecasts Q4 revenues down 8% amid tariff pressures",
            "description": "<html><body><p>Earnings Call Insights: Crocs, Inc. (CROX) Q3 2025  </p>\n<h3>Management View</h3>\n<ul>\n<li>CEO Andrew Rees highlighted disciplined management of both the Crocs and HEYDUDE brands, with actions to streamline cost structure and inventory. He stated, \"We delivered very strong profitability and cash flow, which enabled us to repurchase 2.4 million of our outstanding shares and pay down $63 million of debt. These are fundamental levers of our value creation model.\" Rees acknowledged performance was ahead of expectations but not at the company's standards, emphasizing efforts to regain marketplace momentum through cost reductions and strategic brand actions.</li>\n<li>For the Crocs brand, Rees described two strategic moves: scaling back promotional activity in North American digital channels and reducing wholesale receipts to align supply with demand. He noted, \"While these actions are impacting near-term sales, we expect them to enable a foundation for future growth.\"</li>\n<li>Rees detailed ongoing product innovation, including the introduction of the crafted clog at $60 and successful launches such as the Echo RO. He pointed to international expansion, stating, \"China delivered revenue growth across all channels and was up mid-20% to prior year.\"</li>\n<li>For HEYDUDE, Rees said the brand is stabilizing in North America, with campaigns like HEYDUDE Country and new product launches. He explained, \"We are encouraged to see the brands return to the top 10 preferred footwear brands among males in the Piper Sandler Taking Stock With Teens survey this fall.\"</li>\n<li>Rees announced an additional $100 million in identified gross cost savings for the business, to follow $50 million previously actioned in 2025.</li>\n<li>CFO Patraic Reagan stated, \"Our third quarter revenue of approximately $1 billion were down 7% to prior year. Crocs Brand revenue of $836 million was down 3% to prior year, with wholesale down 8% and DTC up 1%.\" Reagan added, \"Adjusted diluted earnings per share of $2.92 was down 19% to last year, and our non-GAAP effective tax rate was 16.9%.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Crocs expects Q4 revenues to be down approximately 8% at October 27 currency rates. Reagan indicated, \"We expect the Crocs brand to be down approximately 3% with acceleration in our international business from a mid-single digit in Q3 to a low double-digit rate in Q4. North America revenue is expected to be down low double digits to prior year. For HEYDUDE, we expect revenue to be down in the mid-20s range.\"</li>\n<li>Adjusted operating margin is projected at approximately 15.5% for Q4, excluding about $10 million related to cost reduction initiatives. Gross margins are anticipated to be down about 300 basis points due to tariff headwinds. Adjusted diluted EPS is expected in the range of $1.82 to $1.92.</li>\n<li>Reagan stated, \"We are already benefiting from the previously actioned $50 million of gross cost savings in 2025. In addition, we have identified $100 million of incremental gross cost savings that we expect to benefit 2026.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Crocs reported third quarter revenue of approximately $1 billion, a 7% decrease year-over-year. Crocs brand revenue was $836 million, down 3%, with wholesale down 8% and DTC up 1%. North America revenue declined 9%, with international revenue up 4%.</li>\n<li>HEYDUDE revenue was $160 million, down 22% year-over-year. DTC for HEYDUDE was down 1%, driven by retail store additions and TikTok Shop performance, while wholesale dropped 39% due to marketplace cleanup actions.</li>\n<li>Enterprise adjusted gross margin was 58.5%, down 110 basis points, with a 230 basis point headwind from tariffs. Adjusted operating margin was 20.8%, exceeding guidance but down 460 basis points. Adjusted EPS was $2.92, down 19%.</li>\n<li>Inventory balance stood at $397 million, up 8%, attributed to higher tariffs and product mix, while inventory units were down low single digits. Share repurchases totaled 2.4 million shares for $203 million in the quarter.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Jonathan Komp, Baird: Asked about incremental cost savings and structural changes. Andrew Rees explained efficiencies in supply chain and organizational restructuring, and said, \"We can achieve operating leverage in 2026.\"</li>\n<li>Komp followed up on portfolio management and HEYDUDE. Rees responded, \"We believe HEYDUDE is a strong brand... We're definitely focused on returning it to profitability... not contemplating any portfolio changes at this time.\"</li>\n<li>Chris Nardone, BofA: Queried actions to improve Crocs North America. Rees detailed product innovation, diversification, and digital engagement strategies.</li>\n<li>Tom Nikic, Needham: Asked about HEYDUDE marketplace cleanup. Rees said most cleanup actions will conclude in 2025 with less impact in 2026. Reagan noted, \"Sell-in and inventory levels are in much better line for HEYDUDE.\"</li>\n<li>Adrienne Yih-Tennant, Barclays: Asked about consumer behavior and inventory. Rees observed greater caution among mid- to lower-tier consumers, shopping closer to need. Reagan emphasized strong inventory management and that inventory growth was driven by tariffs.</li>\n<li>Peter McGoldrick, Stifel: Asked about market share in products under $100. Rees described both brands as \"democratic in nature\" with the majority of products under $100.</li>\n<li>Rakesh Patel, Raymond James: Inquired about wholesale order book and innovation. Rees projected continued declines in North America wholesale sell-in but highlighted upcoming product launches and sandals.</li>\n<li>Jay Sole, UBS: Asked about pullbacks on promotions and tariff impact. Rees confirmed promotional pullback spanned the entire quarter; Reagan quantified a 230 basis point tariff headwind for Q3.</li>\n<li>Brooke Roach, Goldman Sachs: Sought clarification on pricing strategy amid tariffs. Rees said, \"We don't price the cost, we price to market,\" with selective price increases planned.</li>\n<li>Aubrey Tianello, BNP Paribas: Requested update on store growth. Rees noted expansion in Europe and Asia, with strong performance from new stores.</li>\n<li>Anna Andreeva, Piper Sandler: Asked about $100 million cost savings cadence and DTC acceleration. Reagan said details on cost savings cadence will be provided in 2026, with North America DTC expected to be stronger in Q4.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts expressed cautious and probing sentiment, focusing on cost savings, revenue trajectory, and the impact of tariffs and consumer caution. Several questions probed structural changes and the sustainability of cost reductions.</li>\n<li>Management maintained a confident and proactive tone in prepared remarks, frequently referencing cost savings, product innovation, and channel management. During Q&amp;A, management addressed challenges directly while reiterating confidence in strategic initiatives and brand health. Rees used phrases like \"we are confident\" and \"we believe\" when discussing future leverage and HEYDUDE's outlook.</li>\n<li>Compared to the previous quarter, analyst tone shifted from concern about revenue headwinds and brand health to deeper scrutiny of structural changes and long-term strategies. Management's tone remained focused on execution and flexibility, with added emphasis on cost controls and inventory discipline.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>In Q2 2025, Crocs reported revenue growth and record gross profit, while Q3 saw a 7% decline in revenue year-over-year. Q2 emphasized international growth and brand diversification, while Q3 focused on cost discipline, inventory control, and managing through tariff impacts.</li>\n<li>Strategic focus shifted from growth and innovation in Q2 to executing cost reductions and stabilizing HEYDUDE in Q3.</li>\n<li>Management tone in Q3 was more cautionary regarding near-term expectations but maintained confidence in long-term brand recovery and efficiency gains. Analysts in Q3 pressed harder on structural changes, cost savings, and the path to renewed growth, reflecting heightened concern over sustained margin pressures and consumer headwinds.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management identified ongoing tariff headwinds as a significant risk, with a 230 basis point impact on gross margin in Q3 and an expected 300 basis point impact in Q4.</li>\n<li>The company acknowledged near-term sales pressure due to strategic pullbacks in promotions and wholesale receipts, especially in North America.</li>\n<li>Analysts raised concerns about consumer caution, particularly among lower-tier consumers, competitive pressures from athletic brands, and the ongoing impact of inventory and marketplace cleanup for HEYDUDE.</li>\n<li>Management is addressing risks through disciplined cost controls, inventory management, and strategic investments in product innovation and digital engagement.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Crocs management is moving decisively to reinforce profitability and lay a foundation for future growth, with $100 million in new cost savings targeted for 2026 and a continued focus on product innovation, international expansion, and digital engagement. While revenue and earnings were down in Q3 2025, proactive measures to manage inventory, reduce costs, and protect brand health are expected to support the company through near-term headwinds, particularly those related to tariffs and consumer caution. Management remains confident in the trajectory for both Crocs and HEYDUDE, emphasizing flexibility and operating leverage as key objectives for the year ahead.</p>\n<p><a href=\"https://seekingalpha.com/symbol/crox/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511965-crocs-outlines-100m-cost-savings-initiative-and-forecasts-q4-revenues-down-8-percent-amid",
            "pub_date": "2025-10-31 05:50:42",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511966",
            "title": "Beneficient regains compliance with some of Nasdaq's listing requirements",
            "description": "<html><body><ul> <li>Beneficient (BENF) has regained compliance with some of Nasdaq's listing rules, the company said citing a letter received from Nasdaq.</li> <li>The company remains noncompliant with respect to the $1.00 per share bid price requirement and must regain compliance within the extension period granted by the Nasdaq Hearings Panel to avoid delisting.</li>\n<li>Beneficient plans to seek stockholder approval to effect a reverse stock split of its common stock, which the company anticipates will allow it to demonstrate compliance with the $1.00 bid price requirement for the requisite minimum 10-consecutive trading day period within the extension period granted by the panel.</li> <li>BENF  <font color=\"green\">+34.34%</font> after hours to  $0.7502.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/20287637-beneficient-regains-compliance-with-nasdaq-periodic-filing-requirement-and-market-value-of\">Press Release</a>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511966-beneficient-regains-compliance-with-some-of-nasdaqs-listing-requirements",
            "pub_date": "2025-10-31 05:50:42",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511962",
            "title": "Federated Hermes declares $0.34 dividend",
            "description": "<html><body><ul>\n<li>Federated Hermes (FHI) declared <a href=\"https://seekingalpha.com/pr/20287495-federated-hermes-inc-reports-record-assets-under-management-with-third-quarter-2025-earnings\" target=\"_blank\">$0.34/share quarterly dividend</a>, in line with previous.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/FHI/dividends/yield?source=news_bullet\">Forward yield</a> 2.88%</li>\n<li>Payable Nov. 14; for shareholders of record Nov. 7; ex-div Nov. 7.</li>\n<li><a href=\"https://seekingalpha.com/symbol/FHI/dividends?source=news_bullet\">See FHI Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511962-federated-hermes-declares-0_34-dividend",
            "pub_date": "2025-10-31 05:45:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511963",
            "title": "Alerus Financial GAAP EPS of $0.65 beats by $0.06, revenue of $72.57M beats by $1.18M",
            "description": "<html><body><ul>\n<li>Alerus Financial <a href=\"https://seekingalpha.com/pr/20287613-alerus-financial-corporation-reports-third-quarter-2025-net-income-of-16_9-million\">press release</a>  (ALRS): Q3  GAAP EPS of $0.65 <font color=\"green\"> beats by $0.06</font>.</li>\n<li>Revenue of $72.57M (+42.6% Y/Y) <font color=\"green\"> beats by $1.18M</font>.</li>\n</ul></body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511963-alerus-financial-gaap-eps-of-0_65-beats-by-0_06-revenue-of-72_57m-beats-by-1_18m",
            "pub_date": "2025-10-31 05:45:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511940",
            "title": "Knight Therapeutics announces launch of JORNAY PM",
            "description": "<html><body><ul>\n<li>Knight Therapeutics (<span class=\"ticker-hover-wrapper\">GUD:CA</span>) <a href=\"https://seekingalpha.com/pr/20287623-knight-therapeutics-announces-launch-of-jornay-pm-in-canada\" target=\"_blank\" title=\" announced \"> announced </a>on Thursday the launch of JORNAY PM (methylphenidate HCI extended-release capsules) in Canada, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children 6-12 years of age.</li>\n<li>The company had entered into an agreement with Ironshore Pharmaceuticals &amp; Development, a wholly owned subsidiary of Ironshore Therapeutics, for JORNAY PM, approved in November 2024 to start distribution in Canada and Latin America. </li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511940-knight-therapeutics-announces-launch-of-jornay-pm",
            "pub_date": "2025-10-31 05:40:44",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511955",
            "title": "Savers Value Village Non-GAAP EPS of $0.14 in-line, revenue of $426.93M in-line",
            "description": "<html><body><ul>\n<li>Savers Value Village <a href=\"https://seekingalpha.com/pr/20287336-savers-value-village-inc-reports-third-quarter-financial-results\">press release</a>  (SVV): Q3  Non-GAAP EPS of $0.14 in-line.</li>\n<li>Revenue of $426.93M (+8.1% Y/Y) in-line.</li>\n<li>\n<p>The Company is updating its outlook for the fifty-three weeks ending January 3, 2026 (“fiscal 2025”) as follows:</p>\n<div><div class=\"table-responsive\">\n<span class=\"sa-table-scroll-wrapper sa-hide-scrollbar\"><span data-intersection-boundary=\"start\" data-test-id=\"table-scroll-wrapper-boundary-start\"></span><div class=\"table-responsive\">\n<span class=\"sa-table-scroll-wrapper sa-hide-scrollbar\"><span data-intersection-boundary=\"start\" data-test-id=\"table-scroll-wrapper-boundary-start\"></span><table><tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>Current</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>Previous</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Net sales</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$1.67 billion to $1.68 billion</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$1.67 billion to $1.69 billion</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Comparable store sales growth over fiscal 2024<sup>2</sup></p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>4.0% to 4.5%</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>3.0% to 4.5%</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Net income</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$17 million to $21 million, or $0.10 to $0.13 per diluted share</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$47 million to $58 million, or $0.29 to $0.36 per diluted share</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Adjusted net income<sup>3</sup></p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$71 million to $75 million, or $0.44 to $0.46 per diluted share</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$67 million to $78 million, or $0.41 to $0.48 per diluted share</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Adjusted EBITDA<sup>3</sup></p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$252 million to $257 million</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$252 million to $267 million</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Capital expenditures</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$105 million to $120 million</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$125 million to $140 million</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>New store openings</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>25</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>25</p></td>\n</tr>\n</tbody></table>\n<span data-intersection-boundary=\"end\" data-test-id=\"table-scroll-wrapper-boundary-end\"></span></span><button class=\"sa-table-enlarge-button\" type=\"button\">Click to enlarge</button>\n</div>\n<span data-intersection-boundary=\"end\" data-test-id=\"table-scroll-wrapper-boundary-end\"></span></span><button class=\"sa-table-enlarge-button\" type=\"button\">Click to enlarge</button>\n</div></div>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511955-savers-value-village-non-gaap-eps-of-0_14-in-line-revenue-of-426_93m-in-line",
            "pub_date": "2025-10-31 05:40:44",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511879",
            "title": "Stryker down despite boosting 2025 outlook and Q3 beats",
            "description": "<html><body><ul>\n<li>Stryker (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/SYK\" title=\"Stryker Corporation\">SYK</a></span></span></span>) is <span style=\"color: #ff0000;\">down ~3%</span> in after-hours trading Thursday despite raising its 2025 EPS outlook and having a <a href=\"https://seekingalpha.com/news/4511736-stryker-non-gaap-eps-of-3_19-beats-by-0_06-revenue-of-6_06b-beats-by-20m\" target=\"_self\" title=\"double beat\">double beat</a> in its Q3 results.</li>\n<li>Non-GAAP EPS is now seen at $13.50-$13.60, up from $13.40-$13.60 prior. Consensus is $13.49.</li>\n<li>Organic sales growth is now expected to rise 9.8%-10.2% compared to 2024, up from 9.5%-10%.</li>\n<li>Sales in Stryker's largest business, MedSurg and Neurotechnology, rose 14.4% to ~$3.8B. In the Orthopedics segment, revenue rose 12.5% to ~$2.2B.</li>\n<li>Non-GAAP EPS in Q3 of $3.19 compares to $2.87 in the year-ago period.</li>\n<li>Stryker had cash and cash equivalents of ~$3.3B at the end of the quarter (Sept. 30) compared to ~$3.7B on Dec. 31, 2024.</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511879-stryker-down-despite-boosting-2025-outlook-q3-beats",
            "pub_date": "2025-10-31 05:35:51",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511949",
            "title": "Nexa Resources reports Q3 results",
            "description": "<html><body><ul>\n<li>Nexa Resources <a href=\"https://seekingalpha.com/pr/20287576-nexa-resources-reports-strong-3q25-results-with-net-income-of-us-100-million\">press release</a>  (NEXA): Q3 net income of $100 million in 3Q25, compared to $13 million in 2Q25 and $6 million in 3Q24.</li>\n<li>Adjusted net income was $27 million for the quarter.</li>\n<li>Revenue of $764M (+7.8% Y/Y) <font color=\"green\"> beats by $13.51M</font>.</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511949-nexa-resources-reports-q3-results",
            "pub_date": "2025-10-31 05:35:51",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511945",
            "title": "Capstone Copper GAAP EPS of $0.32, revenue of $598.4M beats by $59.35M",
            "description": "<html><body><ul>\n<li>Capstone Copper <a href=\"https://seekingalpha.com/pr/20287490-capstone-copper-reports-third-quarter-2025-results\">press release</a>  (CSCCF): Q3  GAAP EPS of $0.32.</li>\n<li>Revenue of $598.4M (+42.7% Y/Y) <font color=\"green\"> beats by $59.35M</font>.</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511945-capstone-copper-gaap-eps-of-0_32-revenue-of-598_4m-beats-by-59_35m",
            "pub_date": "2025-10-31 05:30:45",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511946",
            "title": "Alignment Healthcare GAAP EPS of $0.02 beats by $0.09, revenue of $993.7M beats by $12.35M",
            "description": "<html><body><ul>\n<li>Alignment Healthcare <a href=\"https://seekingalpha.com/pr/20287294-alignment-healthcare-reports-third-quarter-2025-results-surpasses-high-end-of-guidance-across\">press release</a>  (ALHC): Q3  GAAP EPS of $0.02 <font color=\"green\"> beats by $0.09</font>.</li>\n<li>Revenue of $993.7M (+43.5% Y/Y) <font color=\"green\"> beats by $12.35M</font>.</li>\n<li>\n<p>Outlook for Q4 and fiscal year 2025</p>\n<div><div class=\"table-responsive\">\n<span class=\"sa-table-scroll-wrapper sa-hide-scrollbar\"><span data-intersection-boundary=\"start\" data-test-id=\"table-scroll-wrapper-boundary-start\"></span><div class=\"table-responsive\">\n<span class=\"sa-table-scroll-wrapper sa-hide-scrollbar\"><span data-intersection-boundary=\"start\" data-test-id=\"table-scroll-wrapper-boundary-start\"></span><table><tbody>\n<tr>\n<td> </td>\n<td colspan=\"2\">Three Months EndingDecember 31, 2025</td>\n<td> </td>\n<td colspan=\"2\">Twelve Months EndingDecember 31, 2025</td>\n</tr>\n<tr>\n<td><em>$ Millions</em></td>\n<td>Low</td>\n<td>High</td>\n<td> </td>\n<td>Low</td>\n<td>High</td>\n</tr>\n<tr>\n<td>Health Plan Membership</td>\n<td>232,500</td>\n<td>234,500</td>\n<td> </td>\n<td>232,500</td>\n<td>234,500</td>\n</tr>\n<tr>\n<td>Revenue</td>\n<td>$995</td>\n<td>$1,010</td>\n<td> </td>\n<td>$3,931</td>\n<td>$3,946</td>\n</tr>\n<tr>\n<td>Adjusted Gross Profit</td>\n<td>$104</td>\n<td>$113</td>\n<td> </td>\n<td>$474</td>\n<td>$483</td>\n</tr>\n<tr>\n<td>Adjusted EBITDA</td>\n<td>$(9)</td>\n<td>$(1)</td>\n<td> </td>\n<td>$90</td>\n<td>$98 </td>\n</tr>\n</tbody></table>\n<span data-intersection-boundary=\"end\" data-test-id=\"table-scroll-wrapper-boundary-end\"></span></span><button class=\"sa-table-enlarge-button\" type=\"button\">Click to enlarge</button>\n</div>\n<span data-intersection-boundary=\"end\" data-test-id=\"table-scroll-wrapper-boundary-end\"></span></span><button class=\"sa-table-enlarge-button\" type=\"button\">Click to enlarge</button>\n</div></div>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511946-alignment-healthcare-gaap-eps-of-0_02-beats-by-0_09-revenue-of-993_7m-beats-by-12_35m",
            "pub_date": "2025-10-31 05:30:45",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}